Literature DB >> 29136240

Postmortem Autopsy-Confirmation of Antemortem [F-18]FDDNP-PET Scans in a Football Player With Chronic Traumatic Encephalopathy.

Bennet Omalu1, Gary W Small2, Julian Bailes3, Linda M Ercoli2, David A Merrill2, Koon-Pong Wong4, Sung-Cheng Huang4, Nagichettiar Satyamurthy4, Jennifer L Hammers5, John Lee6, Robert P Fitzsimmons7, Jorge R Barrio4.   

Abstract

Currently, only presumptive diagnosis of chronic traumatic encephalopathy (CTE) can be made in living patients. We present a modality that may be instrumental to the definitive diagnosis of CTE in living patients based on brain autopsy confirmation of [F-18]FDDNP-PET findings in an American football player with CTE. [F-18]FDDNP-PET imaging was performed 52 mo before the subject's death. Relative distribution volume parametric images and binding values were determined for cortical and subcortical regions of interest. Upon death, the brain was examined to identify the topographic distribution of neurodegenerative changes. Correlation between neuropathology and [F-18]FDDNP-PET binding patterns was performed using Spearman rank-order correlation. Mood, behavioral, motor, and cognitive changes were consistent with chronic traumatic myeloencephalopathy with a 22-yr lifetime risk exposure to American football. There were tau, amyloid, and TDP-43 neuropathological substrates in the brain with a differential topographically selective distribution. [F-18]FDDNP-PET binding levels correlated with brain tau deposition (rs = 0.59, P = .02), with highest relative distribution volumes in the parasagittal and paraventricular regions of the brain and the brain stem. No correlation with amyloid or TDP-43 deposition was observed. [F-18]FDDNP-PET signals may be consistent with neuropathological patterns of tau deposition in CTE, involving areas that receive the maximal shearing, angular-rotational acceleration-deceleration forces in American football players, consistent with distinctive and differential topographic vulnerability and selectivity of CTE beyond brain cortices, also involving midbrain and limbic areas. Future studies are warranted to determine whether differential and selective [F-18]FDDNP-PET may be useful in establishing a diagnosis of CTE in at-risk patients.
Copyright © 2017 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Antemortem; Autopsy; CTE; Football player; [F-18]FDDNP-PET

Mesh:

Year:  2018        PMID: 29136240      PMCID: PMC6685403          DOI: 10.1093/neuros/nyx536

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  15 in total

1.  Letter to the Editor: Editorial: Do Orthopaedic Surgeons Belong on the Sidelines at American Football Games?

Authors:  Brent D Bates; Lucas W Mayer; Ikechukwu C Amakiri; Forrest Rackard; Miguel A Reyes-Zaragoza; Charles F Carr
Journal:  Clin Orthop Relat Res       Date:  2018-04       Impact factor: 4.176

Review 2.  Emerging advances of in vivo detection of chronic traumatic encephalopathy and traumatic brain injury.

Authors:  Julian D Dallmeier; Somayeh Meysami; David A Merrill; Cyrus A Raji
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

3.  Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.

Authors:  Michael L Alosco; Yi Su; Thor D Stein; Eric M Reiman; Ann C McKee; Robert A Stern; Hillary Protas; Jonathan D Cherry; Charles H Adler; Laura J Balcer; Charles Bernick; Surya Vamsi Pulukuri; Bobak Abdolmohammadi; Michael J Coleman; Joseph N Palmisano; Yorghos Tripodis; Jesse Mez; Gil D Rabinovici; Kenneth L Marek; Thomas G Beach; Keith A Johnson; Bertrand Russell Huber; Inga Koerte; Alexander P Lin; Sylvain Bouix; Jeffrey L Cummings; Martha E Shenton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-24       Impact factor: 10.057

Review 4.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

Review 5.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

Review 6.  Chronic Traumatic Encephalopathy in Professional American Football Players: Where Are We Now?

Authors:  Tharmegan Tharmaratnam; Mina A Iskandar; Tyler C Tabobondung; Iqdam Tobbia; Prasaanthan Gopee-Ramanan; Taylor A Tabobondung
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

7.  Alzheimer's Dementia due to Suspected CTE from Subconcussive Head Impact.

Authors:  Shauna H Yuan; Sonya G Wang
Journal:  Case Rep Neurol Med       Date:  2018-07-31

Review 8.  Neuroimaging Biomarkers of New-Onset Psychiatric Disorders Following Traumatic Brain Injury.

Authors:  Andrew R Mayer; Davin K Quinn
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 13.382

9.  Bibliometric Analysis of Chronic Traumatic Encephalopathy Research from 1999 to 2019.

Authors:  Bote Qi; Shuting Jin; Hongsheng Qian; Yu Zou
Journal:  Int J Environ Res Public Health       Date:  2020-07-28       Impact factor: 3.390

10.  Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure.

Authors:  Dara L Dickstein; Rita De Gasperi; Miguel A Gama Sosa; Georgina Perez-Garcia; Jennifer A Short; Heidi Sosa; Gissel M Perez; Anna E Tschiffely; Kristen Dams-O'Connor; Mariel Y Pullman; Karin Knesaurek; Andrew Knutsen; Dzung L Pham; Lale Soleimani; Barry D Jordan; Wayne A Gordon; Bradley N Delman; Gleb Shumyatsky; Pashtun-Poh Shahim; Steven T DeKosky; James R Stone; Elaine Peskind; Kaj Blennow; Henrik Zetterberg; Steven A Chance; Mario Torso; Lale Kostakoglu; Mary Sano; Patrick R Hof; Stephen T Ahlers; Sam Gandy; Gregory A Elder
Journal:  Mol Psychiatry       Date:  2020-02-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.